CLL Panel DeletionDuplication Detection Test sale cost 2100 AED
All PCR Panel Cytogenetics and PCR BCR-ABL TEL-AML1 MLL E2A Test sale cost 2300 AED All PCR Panel Cytogenetics and PCR BCR-ABL TEL-AML1 MLL E2A Test Cost 3,000 د.إ Original price was: 3,000 د.إ.2,300 د.إCurrent price is: 2,300 د.إ.
DMD BMD Mutation Screening 26 Exons Prenatal Test sale cost 2100 AED DMD BMD Mutation Screening 26 Exons Prenatal Test Cost 2,800 د.إ Original price was: 2,800 د.إ.2,100 د.إCurrent price is: 2,100 د.إ.
Sale!

CLL Panel DeletionDuplication Detection Test Cost

Original price was: 2,800 د.إ.Current price is: 2,100 د.إ.

-25%

The CLL Panel Deletion/Duplication Detection Test is a specialized genetic test offered by DNA Labs UAE, designed to identify chromosomal deletions and duplications associated with Chronic Lymphocytic Leukemia (CLL). CLL is a type of cancer that affects the blood and bone marrow, and the presence of specific genetic abnormalities can influence both the prognosis and treatment strategies for individuals diagnosed with this condition. This test analyzes multiple genes known to be relevant in CLL to detect any genetic alterations that might be present.

The cost of the CLL Panel Deletion/Duplication Detection Test at DNA Labs UAE is 2100 AED. This comprehensive test is conducted in a state-of-the-art facility, ensuring accurate and reliable results. By identifying genetic mutations, healthcare providers can tailor treatment plans more effectively to the needs of each patient, potentially improving outcomes. This test is an invaluable tool for both the diagnosis and management of Chronic Lymphocytic Leukemia, offering insights that could lead to more personalized and effective treatment approaches.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

CLL Panel DeletionDuplication detection Test – Cost AED 2100.0

Are you concerned about chronic lymphocytic leukemia (CLL)? DNA Labs UAE offers the CLL Panel DeletionDuplication detection Test, a comprehensive genetic test that can provide valuable insights into this type of cancer. With a price of AED 2100.0, this test is accessible and affordable for individuals seeking accurate diagnosis and personalized treatment options.

Test Name: CLL Panel DeletionDuplication detection Test

Components: EDTA Vacutainer (2ml)

Price: 2100.0 AED

Sample Condition: Bone marrow / Peripheral blood (Transport immediately)

Report Delivery: 7-10 days

Method: MLPA

Test Type: Genetics

Doctor: Oncology

Test Department: DNA Labs UAE

Pre Test Information

CLL Panel Deletion/Duplication detection test requires a doctor’s prescription. However, it is important to note that this test is not applicable for surgery and pregnancy cases, as well as individuals planning to travel abroad.

Test Details

The CLL Panel DeletionDuplication detection test is a cytogenetic process specifically designed to identify and analyze abnormalities in the chromosome 13q14 region. This region is commonly associated with chronic lymphocytic leukemia (CLL), a type of cancer that affects the white blood cells.

Deletion and duplication of genetic material in the 13q14 region are frequently observed in CLL patients. These genetic abnormalities can have prognostic implications and significantly impact the treatment approach. To detect panel deletions or duplications, advanced laboratory techniques such as fluorescence in situ hybridization (FISH) and array comparative genomic hybridization (aCGH) are employed.

FISH involves using fluorescently labeled DNA probes that bind to specific regions of the chromosome, allowing for the visualization of deletions or duplications. On the other hand, aCGH compares the patient’s DNA sample to a reference sample, identifying differences in copy number across the genome.

The identification of panel deletions or duplications in CLL patients is crucial for risk stratification and treatment decisions. Patients with certain genetic abnormalities may have a more aggressive disease course and may require more intensive therapies. Additionally, the detection of these abnormalities can also help in monitoring disease progression and response to treatment.

Overall, the CLL Panel DeletionDuplication detection test plays a crucial role in the management of CLL patients, aiding in risk assessment, treatment planning, and disease monitoring.

Test Name CLL Panel DeletionDuplication detection Test
Components EDTA Vacutainer (2ml)
Price 2100.0 AED
Sample Condition Bone marrow \/ Peripheral blood (Transport immediately)
Report Delivery 7-10 days
Method MLPA
Test type Genetics
Doctor Oncology
Test Department:
Pre Test Information CLL Panel Deletion/Duplication detection can be done with a Doctors prescription. Prescription is not applicable for surgery and pregnancy cases or people planing to travel abroad.
Test Details

CLL Panel Deletion/Duplication detection refers to a process used in the field of cytogenetics to identify and analyze abnormalities in the chromosome 13q14 region. This region is commonly associated with chronic lymphocytic leukemia (CLL), a type of cancer that affects the white blood cells.

Deletion and duplication of genetic material in the 13q14 region are frequent genetic abnormalities observed in CLL patients. These abnormalities can have prognostic implications and impact the treatment approach.

To detect panel deletions or duplications, various laboratory techniques are employed, such as fluorescence in situ hybridization (FISH) and array comparative genomic hybridization (aCGH). FISH involves using fluorescently labeled DNA probes that bind to specific regions of the chromosome, allowing visualization of deletions or duplications. aCGH, on the other hand, compares the patient’s DNA sample to a reference sample, identifying differences in copy number across the genome.

The identification of panel deletions or duplications in CLL patients is essential for risk stratification and treatment decisions. Patients with certain genetic abnormalities may have a more aggressive disease course and may require more intensive therapies. Additionally, the detection of these abnormalities can also help in monitoring disease progression and response to treatment.

Overall, CLL Panel Deletion/Duplication detection plays a crucial role in the management of CLL patients, aiding in risk assessment, treatment planning, and disease monitoring.

SKU: TEST-4864 Category:

Related products